The crystal structure of pertussis toxin.

[1]  J. Wilson,et al.  Neurological complications of pertussis inoculation , 1974, Archives of disease in childhood.

[2]  Y. Sato,et al.  Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. , 1976, Biochimica et biophysica acta.

[3]  J. Munoz,et al.  Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis , 1981, Infection and immunity.

[4]  T. Katada,et al.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. , 1982, Biochemistry.

[5]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[6]  E. Hewlett,et al.  Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). , 1983, The Journal of biological chemistry.

[7]  Noriyoshi Sakabe,et al.  A Focusing Weissenberg Camera with Multi-Layer-Line Screens for Macromolecular Crystallography , 1983 .

[8]  M. Ui,et al.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. , 1983, The Journal of biological chemistry.

[9]  M. Pittman.  The concept of pertussis as a toxin‐mediated disease , 1984, Pediatric infectious disease.

[10]  Yuji Sato,et al.  Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system , 1984, Infection and immunity.

[11]  C DeLisi,et al.  The detection and classification of membrane-spanning proteins. , 1985, Biochimica et biophysica acta.

[12]  E. Tuomanen,et al.  Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. , 1985, The Journal of infectious diseases.

[13]  D. Mckay,et al.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. A. Jones,et al.  Using known substructures in protein model building and crystallography. , 1986, The EMBO journal.

[15]  D. Burns,et al.  Adenine nucleotides promote dissociation of pertussis toxin subunits. , 1986, The Journal of biological chemistry.

[16]  C. Locht,et al.  Pertussis toxin gene: nucleotide sequence and genetic organization. , 1986, Science.

[17]  R. Read.  Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[18]  R. Rappuoli,et al.  Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Vandekerckhove,et al.  Protein‐chemical analysis of pertussis toxin reveals homology between the subunits S2 and S3, between S1 and the A chains of enterotoxins of Vibrio cholerae and Escherichia coli and identifies S2 as the haptoglobin‐binding subunit , 1986, FEBS letters.

[20]  E. Hewlett,et al.  Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. , 1986, Biochemistry.

[21]  D. Burns,et al.  Structural characterization of pertussis toxin A subunit. , 1987, The Journal of biological chemistry.

[22]  M. Karplus,et al.  Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.

[23]  Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. , 1988, The Journal of biological chemistry.

[24]  M. Brennan,et al.  Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. , 1988, The Journal of biological chemistry.

[25]  Randy J. Read,et al.  A phased translation function , 1988 .

[26]  R. Rappuoli,et al.  Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Barbieri,et al.  ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin , 1988, Infection and immunity.

[28]  C Chothia,et al.  Surface, subunit interfaces and interior of oligomeric proteins. , 1988, Journal of molecular biology.

[29]  Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. , 1988 .

[30]  M. Brennan,et al.  Binding of pertussis toxin to eucaryotic cells and glycoproteins , 1989, Infection and immunity.

[31]  C. Locht,et al.  Identification of amino acid residues essential for the enzymatic activities of pertussis toxin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. N. Burnette,et al.  Alkylation of cysteine 41, but not cysteine 200, decreases the ADP-ribosyltransferase activity of the S1 subunit of pertussis toxin. , 1989, The Journal of biological chemistry.

[33]  Role of tryptophan 26 in the NAD glycohydrolase reaction of the S-1 subunit of pertussis toxin. , 1989, The Journal of biological chemistry.

[34]  M. Klein,et al.  A unique sequence of the Bordetella pertussis toxin operon. , 1989, Nucleic acids research.

[35]  S. Cockle.  Identification of an active‐site residue in subunit S1 of pertussis toxin by photocrosslinking to NAD , 1989, FEBS letters.

[36]  Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit , 1989, Infection and immunity.

[37]  Role of cysteine 41 of the A subunit of pertussis toxin. , 1989, The Journal of biological chemistry.

[38]  T. Higashi.  The processing of diffraction data taken on a screenless Weissenberg camera for macromolecular crystallography , 1989 .

[39]  G. S. Golden,et al.  Pertussis vaccine and injury to the brain. , 1990, The Journal of pediatrics.

[40]  C. Schutt,et al.  Preliminary X-ray crystallographic analysis of holotoxin from Bordetella pertussis. , 1990, Journal of molecular biology.

[41]  C. Wright,et al.  2.2 A resolution structure analysis of two refined N-acetylneuraminyl-lactose--wheat germ agglutinin isolectin complexes. , 1990, Journal of molecular biology.

[42]  S. Cockle,et al.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine , 1990, Infection and immunity.

[43]  J. Cherry.  'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is. , 1990, JAMA.

[44]  W. Weis,et al.  Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. , 1991, Science.

[45]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[46]  D. Alkema,et al.  A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin. , 1991, Molecular immunology.

[47]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[48]  J. Barbieri,et al.  Protease treatment of pertussis toxin identifies the preferential cleavage of the S1 subunit. , 1991, The Journal of biological chemistry.

[49]  T. Sixma,et al.  Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli , 1991, Nature.

[50]  Investigation of the lectin-like binding domains in pertussis toxin using synthetic peptide sequences. Identification of a sialic acid binding site in the S2 subunit of the toxin. , 1992, The Journal of biological chemistry.

[51]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[52]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[53]  W. N. Burnette,et al.  Pertussis toxin has eukaryotic-like carbohydrate recognition domains. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Randy J. Read,et al.  Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli , 1992, Nature.

[55]  Interaction of pertussis toxin with cells and model membranes. , 1992, The Journal of biological chemistry.

[56]  C. Chothia,et al.  Protein architecture: New superfamilies , 1992, Current Biology.

[57]  Wayne A. Hendrickson,et al.  Structure of a C-type mannose-binding protein complexed with an oligosaccharide , 1992, Nature.

[58]  G. Sheldrick.  Tutorial on automated Patterson interpretation to find heavy atoms , 1992 .

[59]  Density modification: theory and practice , 1992 .

[60]  A. Murzin.  OB(oligonucleotide/oligosaccharide binding)‐fold: common structural and functional solution for non‐homologous sequences. , 1993, The EMBO journal.

[61]  S. Cockle,et al.  Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits , 1993, Infection and immunity.

[62]  T. Sixma,et al.  Comparison of the B-pentamers of heat-labile enterotoxin and verotoxin-1: two structures with remarkable similarity and dissimilarity. , 1993, Biochemistry.

[63]  N. Unwin.  Nicotinic acetylcholine receptor at 9 A resolution. , 1993, Journal of molecular biology.

[64]  C. Locht,et al.  Site-specific alterations in the B oligomer that affect receptor- binding activities and mitogenicity of pertussis toxin , 1993, The Journal of experimental medicine.

[65]  T. Sixma,et al.  Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. , 1993, Journal of molecular biology.